Diabetes Information

tag:blogger.com,1999:blog-81043064062660188492011-07-30T20:44:31.917-07:00Diabetes InformationMariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comBlogger2111100tag:blogger.com,1999:blog-8104306406266018849.post-56604302683611502732009-09-01T21:00:00.001-07:002009-09-01T21:00:06.974-07:00Is Winter To Blame For Type 1 Diabetes?

Is Winter To Blame For Type 1 Diabetes? Researchers from Finland have found a correlation between new cases of Type 1 diabetes and winter months. The study analysed data of 31,000 children from 105 diabetes centres across 53 countries found a correlation between the season and the onset of Type 1 diabetes. Of the 42 centres that exhibited this seasonal trend, 28 centres had peaks of diagnosis

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-36832893865057434932009-08-28T03:00:00.001-07:002009-08-28T03:00:06.591-07:00An Investigation Into The Immune Response To Wheat Offers A Clue To The Elusive Cause Of Type 1 Diabetes

An Investigation Into The Immune Response To Wheat Offers A Clue To The Elusive Cause Of Type 1 Diabetes Scientists at the Ottawa Hospital Research Institute and the University of Ottawa have discovered what may be an important clue to the cause of type 1 diabetes. Dr. Fraser Scott and his team tested 42 people with type 1 diabetes and found that nearly half had an abnormal immune response to

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-7230773976600252842009-08-25T21:00:00.001-07:002009-08-25T21:00:08.859-07:00Is Winter To Blame For Type 1 Diabetes?

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-34123611316565818592009-08-23T09:00:00.001-07:002009-08-23T09:00:10.133-07:00Caregivers Of People With Diabetes: Diet And Exercise Plans, Managing Blood Sugar Levels And Reliable Online Information Cited As Top Concerns

Caregivers Of People With Diabetes: Diet And Exercise Plans, Managing Blood Sugar Levels And Reliable Online Information Cited As Top Concerns The Hormone Foundation, the public education affiliate of The Endocrine Society, in collaboration with the National Alliance for Caregiving, released key findings from a first-of-its-kind survey aimed at better understanding the daily needs and struggles

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-23769298825639943952009-08-23T03:00:00.001-07:002009-08-23T03:00:08.367-07:00An 'Electronic Tongue' With A Taste For Sweets

An 'Electronic Tongue' With A Taste For Sweets In a new approach to an effective "electronic tongue" that mimics human taste, scientists in Illinois are reporting development of a small, inexpensive, lab-on-a-chip sensor that quickly and accurately identifies sweetness - one of the five primary tastes. It can identify with 100 percent accuracy the full sweep of natural and artificial sweet

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-3867118900536299232009-08-22T15:00:00.001-07:002009-08-22T15:00:07.674-07:00Does Sugar Feed Cancer? New Research Sheds Light On Old Saying

Does Sugar Feed Cancer? New Research Sheds Light On Old Saying Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have uncovered new information on the notion that sugar "feeds" tumors. The findings may also have implications for other diseases such as diabetes. The research is published in the journal Proceedings of the National Academy of Sciences (PNAS). "It's been known

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-25842403579718073882009-08-22T09:00:00.001-07:002009-08-22T09:00:05.834-07:00New Approach To Wound Healing May Be Easy On Skin, But Hard On Bacteria

New Approach To Wound Healing May Be Easy On Skin, But Hard On Bacteria In a presentation to the American Chemical Society meeting, Ankit Agarwal, a postdoctoral researcher at the University of Wisconsin-Madison, described an experimental approach to wound healing that could take advantage of silver's anti-bacterial properties, while sidestepping the damage silver can cause to cells needed for

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-90423811789513203232009-08-22T03:00:00.001-07:002009-08-22T03:00:06.947-07:00Survey Reveals Patients' Concerns About Diabetes Complications

Survey Reveals Patients' Concerns About Diabetes Complications The results of a Diabetes UK survey show that 80 per cent of those surveyed are concerned about having a heart attack, stroke or nerve damage; almost 50 per cent are concerned about experiencing hypoglycaemia; nearly 25 per cent have experienced sexual dysfunction; just under ten per cent have suffered eye damage; and eight per cent

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-88872672793718349862009-08-21T21:00:00.001-07:002009-08-21T21:00:09.067-07:00Does Sugar Feed Cancer? New Research Sheds Light On Old Saying

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-22986077789621940452009-08-21T15:00:00.001-07:002009-08-21T15:00:07.666-07:00Efforts To Create Treatment Guidelines Are Often Complicated

Efforts To Create Treatment Guidelines Are Often Complicated The development of treatment guidelines for illnesses such as diabetes is a complicated process. The New York Times reports: "The goal [of creating guidelines] is to improve treatment and, at the same time, save money. But setting guidelines that are good for every patient... can get messy, with some experts warning that a big national

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-56393576750528786342009-08-21T09:00:00.001-07:002009-08-21T09:00:06.276-07:00GlycoMimetics, Inc. Awarded National Institutes of Health Grant To Study Drug Candidate In Diabetes

GlycoMimetics, Inc. Awarded National Institutes of Health Grant To Study Drug Candidate In Diabetes GlycoMimetics, Inc., a clinical-stage biotechnology company that is developing a new class of glycobiology-based therapies for a broad range of indications, announced it has been awarded a grant from The National Heart, Lung, and Blood Institute (NHLBI) of The National Institutes of Health (NIH) to

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-35759928086395178112009-08-20T15:00:00.001-07:002009-08-20T15:00:07.004-07:00A Drug Used To Treat Type 2 Diabetes Is Associated To Increased Risk Of Heart Failure

A Drug Used To Treat Type 2 Diabetes Is Associated To Increased Risk Of Heart Failure A study just published on bmj.com reports that rosiglitazone, a drug used to treat type 2 diabetes, is linked with an increased risk of heart failure and death among elder patients compared to pioglitazone, which is a similar drug. As a result, the researchers point out it is questionable to support

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-67026727622325204292009-08-20T03:00:00.001-07:002009-08-20T03:00:06.972-07:00Healthy Lifestyle Reduces Risk Of Chronic Conditions

Healthy Lifestyle Reduces Risk Of Chronic Conditions Researchers at the Centre for Disease Control and Prevention in Atlanta studied data from 25,513 adults aged 35 to 65. They found that never smoking, having a body mass index lower than 30, doing physical activity for at least three and a half hours per week, and following a healthy diet, reduce the risk of developing Type 2 diabetes by 93

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-7151690975364149182009-08-19T15:00:00.001-07:002009-08-19T15:00:07.765-07:00Survey Reveals Patients' Concerns About Diabetes Complications

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-46430667540256075962009-08-19T03:00:00.001-07:002009-08-19T03:00:07.119-07:00Treating High Systolic Blood Pressure In Non-Diabetic Patients Could Be Beneficial

Treating High Systolic Blood Pressure In Non-Diabetic Patients Could Be Beneficial Treatment to lower high systolic blood pressure in non-diabetic patients is associated with a reduction in left ventricular hypertrophy (LVH), a thickening of the heart muscle that can lead to heart failure and rhythm problems. Thus, a lowering of systolic blood pressure targets from the currently recommended 140

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-14456115992793310412009-08-18T15:00:00.001-07:002009-08-18T15:00:07.812-07:00More Fruits And Veggies, Less Salt Prevent Kidney Stones From Forming

More Fruits And Veggies, Less Salt Prevent Kidney Stones From Forming Researchers have found another reason to eat well: a healthy diet helps prevent kidney stones. Loading up on fruits, vegetables, nuts, low-fat dairy products, and whole grains, while limiting salt, red and processed meats, and sweetened beverages is an effective way to ward off kidney stones, according to a study appearing in

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-78574759891474844122009-08-18T03:00:00.001-07:002009-08-18T03:00:05.928-07:00Primary Care Needs Of Those Living With HIV Highlighted By Updated Guidelines

Primary Care Needs Of Those Living With HIV Highlighted By Updated Guidelines With HIV patients living longer thanks to advances in treatment, the primary care needs of those living with HIV have never been more important. Updated, evidence-based guidelines from the HIV Medicine Association (HIVMA) and the Infectious Diseases Society of America (IDSA) are designed to help providers manage the

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-54459728666773809862009-08-17T15:00:00.001-07:002009-08-17T15:00:07.534-07:00More Insulin-Producing Cells, At The Flip Of A 'Switch'

More Insulin-Producing Cells, At The Flip Of A 'Switch' Researchers have found a way in mice to convert another type of pancreas cell into the critical insulin-producing beta cells that are lost in those with type I diabetes. The secret ingredient is a single transcription factor, according to the report in the August 7th issue of Cell, a Cell Press journal. When the gene called Pax4 is forced

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-9145525473711040102009-08-17T03:00:00.001-07:002009-08-17T03:00:06.246-07:00Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF

Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF The Juvenile Diabetes Research Foundation has said that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and most

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-50139716081895980032009-08-16T21:00:00.001-07:002009-08-16T21:00:08.803-07:00Supporting Research On Age-Related Diseases And Clinical Care

Supporting Research On Age-Related Diseases And Clinical Care The American Federation for Aging Research (AFAR), The National Institute on Aging (NIA), The Atlantic Philanthropies, The John A. Hartford Foundation, The Starr Foundation and other program partners are pleased to announce the 2009 recipients of the Paul B. Beeson Career Development Awards in Aging Research Program.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-77418103571672402532009-08-16T15:00:00.001-07:002009-08-16T15:00:10.544-07:00Radiation Therapy May Increase Diabetes Risk In Childhood Cancer Survivors

Radiation Therapy May Increase Diabetes Risk In Childhood Cancer Survivors Childhood cancer survivors treated with total body or abdominal radiation may have an increased risk of diabetes, according to a report in the August 10/24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. This correlation does not appear to be related to patients' body mass index or physical

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-79436480566828553142009-08-16T09:00:00.001-07:002009-08-16T09:00:08.438-07:00Bayer Statement On U.S. Food And Drug Administration Advice For Patients: Serious Errors With Certain Blood Glucose Monitoring Test Strips

Bayer Statement On U.S. Food And Drug Administration Advice For Patients: Serious Errors With Certain Blood Glucose Monitoring Test Strips Since 2006, Bayer Diabetes Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters. As referenced in a U.S. Food and Drug Administration Advice for

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-78987700839532972452009-08-15T21:00:00.001-07:002009-08-15T21:00:08.335-07:00Reducing Cardiovascular Events: International Insulin Drug Trial

Reducing Cardiovascular Events: International Insulin Drug Trial Accumulating safety data from the large, international ORIGIN trial have been reviewed by its independent data monitoring committee, who have concluded that there is no cause for concern. This six-year study, which is lead by McMaster University professors Dr. Hertzel Gerstein and Dr.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-42836578322750919592009-08-15T09:00:00.001-07:002009-08-15T09:00:06.995-07:00More Fruits And Veggies, Less Salt Prevent Kidney Stones From Forming

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-6850068903714477802009-08-15T03:00:00.001-07:002009-08-15T03:00:06.264-07:00Diabetes: MRI May Help In The Diagnosis, Staging And Treatment

Diabetes: MRI May Help In The Diagnosis, Staging And Treatment Noninvasive imaging (MRI) may aid physicians in the early diagnosis, staging and treatment of diabetes, according to a study performed at Massachusetts General Hospital and Harvard Medical School in Boston, MA. This is the first study of its kind to apply noninvasive imaging techniques to diabetes research.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-84541479715338469562009-08-14T15:00:00.001-07:002009-08-14T15:00:08.376-07:00Rush University Medical Center Hosts Conference Examining Chicago Breastfeeding Rates And Ways To Reduce The Disparities

Rush University Medical Center Hosts Conference Examining Chicago Breastfeeding Rates And Ways To Reduce The Disparities Over 100 certified breastfeeding peer counselors, lactation consultants, nurses, physicians, dietitians and community health workers are expected to gather at Rush University Medical Center on Thursday, August 6 from 8 a.m. until 1 p.m. in Room 500 at 1725 W. Harrison Street,

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-82047670362397187282009-08-14T03:00:00.001-07:002009-08-14T03:00:06.510-07:00Array BioPharma Reports Positive Results Of Its Oral Glucokinase Activator In Type 2 Diabetes Patients

Array BioPharma Reports Positive Results Of Its Oral Glucokinase Activator In Type 2 Diabetes Patients Array BioPharma Inc. announced yesterday positive top-line data from a Phase 1 clinical trial in patients with Type 2 diabetes with its novel small molecule glucokinase activator (GKA), ARRY-403. The drug met its primary and secondary endpoints of safety, pharmacokinetics and glucose control.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-71710562247959393892009-08-13T21:00:00.001-07:002009-08-13T21:00:07.704-07:00Stimulus Funding Helps K-State Biochemist Study Eye's Lens In Diabetes, Galactosemia Patients

Stimulus Funding Helps K-State Biochemist Study Eye's Lens In Diabetes, Galactosemia Patients Thanks to a grant awarded through federal stimulus research funding, a Kansas State University biochemist has more funding for research that could eventually help diabetics preserve their eyesight. Dolores Takemoto, a K-State professor of biochemistry, received more than $366,000 from the National Eye

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-86905297671747901752009-08-13T15:00:00.001-07:002009-08-13T15:00:10.906-07:00Association Between Subjective Symptoms Of Sleep Quality, Daytime Sleepiness And Declining Quality Of Life

Association Between Subjective Symptoms Of Sleep Quality, Daytime Sleepiness And Declining Quality Of Life A study, "Longitudinal Evaluation of Sleep-Disordered Breathing and Sleep Symptoms with Change in Quality of Life: The Sleep Heart Health Study (SHHS)," in the Aug. 1 issue of the journal Sleep indicates that self-reported worsening in initiating and maintaining sleep over a five-year period

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-24346120938219313512009-08-13T03:00:00.001-07:002009-08-13T03:00:09.444-07:00Joslin Study Identifies Gene Linked To Rare Form Of Diabetes

Joslin Study Identifies Gene Linked To Rare Form Of Diabetes Researchers at the Joslin Diabetes Center have linked another gene to a rare form of diabetes, a finding that could prove beneficial to those with the more common type 2 diabetes. In a study published this week in Proceedings of the National Academy of Sciences Early Edition, a team led by Alessandro Doria, M.D., Ph.D. and Rohit N.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-12541131909320798202009-08-12T21:00:00.001-07:002009-08-12T21:00:06.449-07:00Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-45146519720501507732009-08-10T09:00:00.001-07:002009-08-10T09:00:08.690-07:00Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-47722072955196310152009-08-09T21:00:00.001-07:002009-08-09T21:00:07.378-07:00Rates Of Severe Childhood Obesity Have Tripled

Rates Of Severe Childhood Obesity Have Tripled Rates of severe childhood obesity have tripled in the last 25 years, putting many children at risk for diabetes and heart disease, according to a report in Academic Pediatrics by an obesity expert at Brenner Children's Hospital, part of Wake Forest University Baptist Medical Center. "Children are not only becoming obese, but becoming severely

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-51570225889887548982009-08-09T15:00:00.001-07:002009-08-09T15:00:25.188-07:00Rush University Medical Center Hosts Conference Examining Chicago Breastfeeding Rates And Ways To Reduce The Disparities

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-30249486909974727032009-08-09T03:00:00.001-07:002009-08-09T03:00:06.695-07:00More Insulin-Producing Cells, At The Flip Of A 'Switch'

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-35127774265771111822009-08-08T21:00:00.001-07:002009-08-08T21:00:07.854-07:00Diabetes UK Fundraiser On Trafalgar Square's Fourth Plinth

Diabetes UK Fundraiser On Trafalgar Square's Fourth Plinth Richard Chapman, from Selsdon, near Croydon, stood on Trafalgar Square's Fourth Plinth yesterday from 9pm to 10pm to raise funds and awareness for Diabetes UK. The Fourth Plinth in Trafalgar Square, London, is the central part of an art project by Antony Gormley. Called 'One and Other', the project sees a different person, selected

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-42748436721683505412009-08-08T15:00:00.001-07:002009-08-08T15:00:06.358-07:00Online Diabetes Service To Connect People With Clinical Trial Information

Online Diabetes Service To Connect People With Clinical Trial Information The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research, has announced that it has launched an on-line service for people with type 1 diabetes and their families to easily find information about clinical

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-72984317328082846922009-08-08T09:00:00.001-07:002009-08-08T09:00:05.995-07:00Gut Hormone Has 'Remote Control' On Blood Sugar

Gut Hormone Has 'Remote Control' On Blood Sugar A gut hormone first described in 1928 plays an unanticipated and important role in the remote control of blood sugar production in the liver, according to a report in the August 6th Cell Metabolism, a Cell Press publication. What's more, the researchers show that rats fed a high-fat diet for a few days become resistant to the glucose-lowering

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-16959711806264417422009-08-07T21:00:00.001-07:002009-08-07T21:00:12.031-07:00Gut Hormone Has 'Remote Control' On Blood Sugar

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-37594585593414709882009-08-07T15:00:00.001-07:002009-08-07T15:00:08.113-07:00Cancer Treatment Controls Macular Edema Related To Diabetes And To Cataract Surgery

Cancer Treatment Controls Macular Edema Related To Diabetes And To Cataract Surgery This month's Ophthalmology, the journal of the American Academy of Ophthalmology, reports on the use of bevacizumab (Avastin) to benefit diabetic patients with macular edema as well as people who develop cystoid macular edema after cataract surgery. Bevacizumab is also used to treat some cancers. A third study

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-42589159282009396632009-08-07T03:00:00.001-07:002009-08-07T03:00:06.564-07:00Food Additive May One Day Help Control Blood Lipids And Reduce Disease Risk

Food Additive May One Day Help Control Blood Lipids And Reduce Disease Risk Scientists at Washington University School of Medicine in St. Louis have identified a substance in the liver that helps process fat and glucose. That substance is a component of the common food additive lecithin, and researchers speculate it may one day be possible to use lecithin products to control blood lipids and

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-48991023686376211952009-08-06T15:00:00.001-07:002009-08-06T15:00:05.309-07:00U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults

U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-81107702491688435852009-08-06T09:00:00.001-07:002009-08-06T09:00:06.177-07:00From Molecular Physiology To Therapeutic Applications Of Stem Cells

From Molecular Physiology To Therapeutic Applications Of Stem Cells Stem cell research promises remedies to many devastating diseases that are currently incurable, ranging from diabetes and Parkinson's disease to paralysis. Totipotent embryonic stem cells have great potential for generating a wide range of different human cells that can be used to restore malfunctioning or damaged cells and

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-20755483916058652322009-08-06T03:00:00.001-07:002009-08-06T03:00:06.734-07:00New Powder Speeds Healing Of Difficult Foot Wounds

New Powder Speeds Healing Of Difficult Foot Wounds Foot complications, such as open wounds and ulcers, can be one of the most difficult ailments for a podiatrist to treat. However, a new wound dressing powder, which acts very much like a layer of skin, is proving to speed the healing time and reduce the amount of pain that a patient suffering from a serious foot ulcer would normally experience.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-59923209203482415862009-08-05T15:00:00.001-07:002009-08-05T15:00:06.595-07:00Cardium Provides Update On Phase 2b Excellarate Clinical Study And Plans For Additional Tissue Repair Applications

Cardium Provides Update On Phase 2b Excellarate Clinical Study And Plans For Additional Tissue Repair Applications Cardium Therapeutics (NYSE Amex: CXM) and its subsidiary Tissue Repair Company (TRC) provided an update on the completion of their MATRIX Phase 2b clinical study and announced plans to provide detailed safety and efficacy data for their Excellarate(TM) product candidate around the

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-41824550680106191812009-08-05T09:00:00.001-07:002009-08-05T09:00:14.198-07:00International Diabetes Federation Launch Landmark Action Plan To Tackle Rising Diabetes Epidemic In Africa

International Diabetes Federation Launch Landmark Action Plan To Tackle Rising Diabetes Epidemic In Africa The International Diabetes Federation African Region (IDF Africa) launched a critical action plan today to address the escalating threat that diabetes poses to the region. The plan identifies three key areas of action: government, primary healthcare and the community, defining a clear

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-90771624329812996072009-08-05T03:00:00.001-07:002009-08-05T03:00:06.503-07:00Common Diabetic Therapy Reduces Risk Of Pancreatic Cancer

Common Diabetic Therapy Reduces Risk Of Pancreatic Cancer Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Center, published in the Aug. 1 issue of Gastroenterology.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-19219538161950772272009-08-04T21:00:00.001-07:002009-08-04T21:00:13.106-07:00IgM In Urine Acts As Prognostic Indicator In Diabetes

IgM In Urine Acts As Prognostic Indicator In Diabetes A marker of the likely course of diabetic nephropathy (DN) has been found. An 18-year study, published in the open access journal BMC Medicine, has shown that Immunoglobulin M (IgM) is a reliable predictor of cardiovascular complications in DN patients. Omran Bakoush, MD, PhD, led a team of researchers from Lund University, Sweden, who

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-46329981095478020782009-08-04T09:00:00.001-07:002009-08-04T09:00:08.528-07:00Rates Of Severe Childhood Obesity Have Tripled

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-71701171829331331692009-08-03T21:00:00.001-07:002009-08-03T21:00:09.724-07:00International Diabetes Federation Launch Landmark Action Plan To Tackle Rising Diabetes Epidemic In Africa

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-4083984656970525732009-08-03T09:00:00.001-07:002009-08-03T09:00:19.545-07:00International Diabetes Federation Launch Landmark Action Plan To Tackle Rising Diabetes Epidemic In Africa

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-29114332968343013572009-08-03T03:00:00.001-07:002009-08-03T03:00:07.548-07:00Cancer Treatment Controls Macular Edema Related To Diabetes And To Cataract Surgery

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-37311967700358146592009-08-02T21:00:00.001-07:002009-08-02T21:00:09.106-07:00U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-26987885063708524982009-08-02T15:00:00.001-07:002009-08-02T15:00:06.627-07:00Diabetes Gene Raises Odds Of Lower Birth Weight

Diabetes Gene Raises Odds Of Lower Birth Weight Pediatric researchers have found that a gene previously shown to be involved in the development of type 2 diabetes also predisposes children to having a lower birth weight. The finding sheds light on a possible genetic influence on how prenatal events may set the stage for developing diabetes in later childhood or adulthood.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-551067980003074482009-08-02T03:00:00.001-07:002009-08-02T03:00:06.431-07:00American Diabetes Association Launches My Health Advisor -- Online Calculator That Shows Risk For Diabetes, Heart Disease And Stroke

American Diabetes Association Launches My Health Advisor -- Online Calculator That Shows Risk For Diabetes, Heart Disease And Stroke With an estimated 57 million Americans with pre-diabetes, the American Diabetes Association today launches My Health Advisor, an online tool that helps people understand their personal risk for developing type 2 diabetes, heart disease and stroke. My Health Advisor

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-46121802727159771432009-08-01T21:00:00.001-07:002009-08-01T21:00:06.463-07:00U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-78493931721585915782009-08-01T15:00:00.001-07:002009-08-01T15:00:05.705-07:00Online Diabetes Service To Connect People With Clinical Trial Information

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-7840936247060432242009-08-01T03:00:00.001-07:002009-08-01T03:00:06.489-07:00What Does Quality Of Life Mean To You?

What Does Quality Of Life Mean To You? Lifepsychol is a new healthcare initiative designed to focus attention on ways to support and improve the quality of life of people with long term conditions. Lifepsychol is conducting a survey to learn what people mean from the term 'quality of life'. In healthcare, this can mean a person's emotional, physical and mental wellbeing, and their general

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-37375405347036361482009-07-31T21:00:00.001-07:002009-07-31T21:00:37.662-07:00Wiley-Blackwell To Publish Journal Of Diabetes Investigation

Wiley-Blackwell To Publish Journal Of Diabetes Investigation Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), has announced that it will be publishing a new diabetes journal titled Journal of Diabetes Investigation from 2010.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-73004886495193733722009-07-31T09:00:00.001-07:002009-07-31T09:00:05.793-07:00Iron-Binding Drug Could Help Diabetics Heal Stubborn Wounds, Says Stanford/Einstein Study

Iron-Binding Drug Could Help Diabetics Heal Stubborn Wounds, Says Stanford/Einstein Study A drug used to remove iron from the body could help doctors fight one of diabetes' cruelest complications: poor wound healing, which can lead to amputation of patients' toes, feet and even legs. The drug, deferoxamine, helped diabetic mice heal small cuts 10 days faster than those who did not receive

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-10784083727282331392009-07-31T03:00:00.001-07:002009-07-31T03:00:07.267-07:00Follow-Up Study Further Reinforces The Long-Term Benefits Of Tight Glucose Control In Early Treatment Of Diabetes

Follow-Up Study Further Reinforces The Long-Term Benefits Of Tight Glucose Control In Early Treatment Of Diabetes A study published in today's issue of the Archives of Internal Medicine provides further reinforcement that tight control of blood glucose as soon as possible after a diagnosis of type 1 diabetes yields long-term benefits with regard to lowering the rates of eye, kidney and heart

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-2305421704743048382009-07-30T15:00:00.001-07:002009-07-30T15:00:10.204-07:00Diabetes Gene Raises Odds Of Lower Birth Weight

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-22141653731262629172009-07-30T03:00:00.001-07:002009-07-30T03:00:08.870-07:00Follow-Up Study Further Reinforces The Long-Term Benefits Of Tight Glucose Control In Early Treatment Of Diabetes

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-76829936422266461822009-07-29T15:00:00.001-07:002009-07-29T15:00:08.059-07:00Antipsychotic Drugs Associated With High Blood Sugar In Older Adults With Diabetes

Antipsychotic Drugs Associated With High Blood Sugar In Older Adults With Diabetes Older patients with diabetes who take antipsychotic medications appear to have an increased risk of hospitalization for hyperglycemia (elevated blood glucose level), especially soon after beginning treatment, according to a report in the July 27 issue of Archives of Internal Medicine, one of the JAMA/Archives

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-5282617840286001742009-07-29T09:00:00.001-07:002009-07-29T09:00:07.032-07:00Researcher Offers Hope For Male Diabetes Sufferers - Hereditary Diabetes Insipidus

Researcher Offers Hope For Male Diabetes Sufferers - Hereditary Diabetes Insipidus Scientists at Glasgow have made a significant discovery in the study of a rare form of diabetes which predominantly affects men. Hereditary Diabetes Insipidus is, according to experts, the most common genetic disease known in medicine. It causes serious kidney malfunction and can, if untreated, be fatal. There are

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-89559462046912129942009-07-28T21:00:00.001-07:002009-07-28T21:00:18.954-07:00Researchers To Inject People With Diabetes With Cells From Pigs

Researchers To Inject People With Diabetes With Cells From Pigs Researchers are hoping that cells from pigs from a remote group of islands 300 miles from New Zealand could lead to a new treatment for Type 1 diabetes. Some of the pigs have been moved from the islands to mainland New Zealand, where they are being kept in fully enclosed sterile housing. The scientists are trialling the cell

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-58302136481731867242009-07-28T15:00:00.001-07:002009-07-28T15:00:05.893-07:00Last Chance For PCTs To Take Part In Groundbreaking User Involvement Project, UK

Last Chance For PCTs To Take Part In Groundbreaking User Involvement Project, UK Following the announcement that Diabetes UK and NHS Diabetes have joined forces to deliver an innovative project that will support three PCTs in England to develop effective user involvement approaches in diabetes care, the charity has received an excellent response from PCTs wanting to get involved. In order to

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-56554562925782320542009-07-28T03:00:00.001-07:002009-07-28T03:00:08.963-07:00Oramed Pharmaceuticals Reports Positive Results From A Study Of Oral Insulin Capsule On Type 1 Diabetic Patients

Oramed Pharmaceuticals Reports Positive Results From A Study Of Oral Insulin Capsule On Type 1 Diabetic Patients Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, today reported positive results from a Phase 2A study of its oral insulin capsule, ORMD-0801, on type 1 diabetic patients. The completion of this study marks Oramed's first clinical trial

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-47974888504397852812009-07-27T21:00:00.001-07:002009-07-27T21:00:07.017-07:00Advances In Lab-Grown Motor Nerves Can Lead To Cures For Diabetic Neuropathy And Help Further Understand Multiple Sclerosis And Related Conditions

Advances In Lab-Grown Motor Nerves Can Lead To Cures For Diabetic Neuropathy And Help Further Understand Multiple Sclerosis And Related Conditions In the July issue of Biomaterials, published by Elsevier, researchers from the University of Central Florida (UCF) report on the first lab-grown motor nerves that are insulated and organized just like they are in the human body. The model system will

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-44986026045406929412009-07-27T15:00:00.001-07:002009-07-27T15:00:06.953-07:00Diabetes UK Wants To Hear About Your Diabetes Experiences

Diabetes UK Wants To Hear About Your Diabetes Experiences Diabetes UK is looking for people with diabetes to share their experiences of supported self-management to help with our campaign for World Diabetes Day (14 November). As 95 per cent of diabetes care is through self-management, this key issue is one of Diabetes UK's priorities. It is about enabling people with diabetes to have the

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-6164360148605654782009-07-27T03:00:00.001-07:002009-07-27T03:00:05.400-07:00What Is Gangrene? What Causes Gangrene?

What Is Gangrene? What Causes Gangrene? Gangrene occurs when tissue dies (necrosis) because its blood supply is interrupted. Gangrene may be caused by an infection, injury, or a complication of a long-term condition that restricts blood circulation. It most commonly occurs in the extremities - the toes, fingers, arms and legs - but internal organs and muscles may also become gangrenous. There are

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-11721346037720803432009-07-26T15:00:00.001-07:002009-07-26T15:00:08.392-07:00Larry King Talks About His Diabetes For The First Time

Larry King Talks About His Diabetes For The First Time Broadcasting legend Larry King turns the tables to talk about himself in his new autobiography, "My Remarkable Journey," but doesn't mention the chronic disease he's lived with for nearly fifteen years: type 2 diabetes. In an interview with

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-57278010578023285362009-07-26T03:00:00.001-07:002009-07-26T03:00:14.558-07:00Diabetes Educators Get First Taste Of Nevella(R) With Probiotics, The Only Sweetener Designed To Boost The Immune System

Diabetes Educators Get First Taste Of Nevella(R) With Probiotics, The Only Sweetener Designed To Boost The Immune System Designed to boost the immune system and promote health, probiotics are gaining popularity at the grocery, and Nevella® with Probiotics, made by Heartland Sweeteners, is the first and only such sweetener currently on the market. Diabetes educators will get an early preview of

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-74944002827712819512009-07-25T15:00:00.001-07:002009-07-25T15:00:06.736-07:00Grapefruit Ingredient - A Future Treatment For Type 2 Diabetes?

Grapefruit Ingredient - A Future Treatment For Type 2 Diabetes? A team of Canadian scientists have discovered that naringenin, a flavonoid found in citrus fruit, and especially grapefruit, makes the liver burn fat instead of storing it after a meal. (This chemical compound also gives grapefruit its bitter taste.) Potentially, without having to change diets or cut out particular foods, a dose of

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-2495700917068697282009-07-25T09:00:00.001-07:002009-07-25T09:00:08.946-07:00Trinity Biotech Announces TRI-statTM CLIA Submission To FDA

Trinity Biotech Announces TRI-statTM CLIA Submission To FDA Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced it has submitted its CLIA application for its TRI-stat™ point-of-care HbA1c product to the FDA. TRI-stat™ is designed to measure HbA1c, also known as glycated hemoglobin, a

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-76801650251371615982009-07-25T03:00:00.001-07:002009-07-25T03:00:07.638-07:00OneTouch(R) Ping™ Glucose Management System Approved By Health Canada

OneTouch(R) Ping™ Glucose Management System Approved By Health Canada Animas Corporation announcedthe approval of its OneTouch® Ping™ Glucose Management System by Health Canada. OneTouch Ping is the first full-feature insulin pump that wirelessly communicates with a blood glucose meter-remote. Using the OneTouch Ping meter-remote, a person can calculate insulin doses and opt to wirelessly

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-37074906972684622602009-07-24T15:00:00.001-07:002009-07-24T15:00:06.752-07:00FDA Approves NovoLog(R) Labeling Update - Increasing The Time Patients Can Use And Store NovoLog(R) In Their Pumps From Two Days To Six Days

FDA Approves NovoLog(R) Labeling Update - Increasing The Time Patients Can Use And Store NovoLog(R) In Their Pumps From Two Days To Six Days Diabetes patients taking NovoLog® (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration (FDA) approval of a labeling change, diabetes care company Novo Nordisk

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-24973459325247792582009-07-23T09:00:00.001-07:002009-07-23T22:10:07.727-07:00Halozyme Begins Phase 2 Clinical Trial Of Insulin-PH20 In Type 2 Diabetic Patients

Halozyme Begins Phase 2 Clinical Trial Of Insulin-PH20 In Type 2 Diabetic Patients Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced the commencement of patient dosing in a Phase 2 clinical study of Insulin-PH20 in patients with Type 2 Diabetes Mellitus. This randomized cross-over design study is designed to compare the postprandial glycemic excursions following a standardized test meal

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-17431191271642382242009-07-23T03:00:00.001-07:002009-07-23T22:10:07.731-07:00Yale Discovery May Open Door To Drug That Cuts Appetite And Boosts Energy

Yale Discovery May Open Door To Drug That Cuts Appetite And Boosts Energy In a major advance in obesity and diabetes research, Yale School of Medicine scientists have found that reducing levels of a key enzyme in the brain decreased appetites and increased energy levels. Reductions in the levels of the enzyme prolylcarboxypeptidase (PRCP) led to weight loss and a decreased risk of type 2

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-59819627958690032142009-07-22T15:00:00.001-07:002009-07-23T22:10:07.738-07:00Reliv International's GlucAffect(TM) Proven Effective In Clinical Study

Reliv International's GlucAffect(TM) Proven Effective In Clinical Study A clinical study published in the journal Phytotherapy Research found that GlucAffect, a nutritional supplement developed by Reliv International, Inc. (Nasdaq: RELV), significantly reduced blood glucose levels and helped control weight in study participants. The study included 50 overweight individuals who had

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-89025524073975775022009-07-22T09:00:00.001-07:002009-07-23T22:10:07.745-07:00Expert Statement Issued About Lantus(R) Following Recent Publications In Diabetologia

Expert Statement Issued About Lantus(R) Following Recent Publications In Diabetologia Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced the release of an Expert Statement by a multidisciplinary board of renowned international experts following an in-depth assessment of the recent publications of registry analyses with Lantus(R) (insulin glargine [rDNA] injection) in Diabetologia.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-36752140275064148962009-07-21T09:00:00.001-07:002009-07-21T09:00:07.422-07:00OneTouch(R) Ping™ Glucose Management System Approved By Health Canada

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-77691591459692231792009-07-21T03:00:00.001-07:002009-07-21T03:00:05.794-07:00New Blood Glucose Meter Connects To Gaming Systems

New Blood Glucose Meter Connects To Gaming Systems A new blood glucose monitor, unveiled today, connects directly to Nintendo DST and Nintendo DST Lite gaming systems and was designed specifically for children with diabetes. The Didget meter aims to encourage children to build good blood glucose testing habits by awarding points that children can use to unlock new game levels and customise

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-87156866165310531552009-07-20T21:00:00.001-07:002009-07-20T21:00:07.492-07:00FDA Approves NovoLog(R) Labeling Update

FDA Approves NovoLog(R) Labeling Update Diabetes patients taking NovoLog((R)) (insulin aspart [rDNA origin] injection) can now use the insulin in their pump for up to six days following the U.S. Food and Drug Administration (FDA) approval of a labeling change, diabetes care company Novo Nordisk announced today.(1) The previous label allowed for NovoLog((R)) to be stored in the pump reservoir for

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-30353019462152485072009-07-20T09:00:00.001-07:002009-07-20T09:00:06.149-07:00Young Black Women Prone To Gain More Unhealthy Abdominal Fat Than Hispanics

Young Black Women Prone To Gain More Unhealthy Abdominal Fat Than Hispanics Black women ages 20 to 29 are more prone to pack on unhealthy abdominal and visceral fat than Hispanic women the same age, and as compared to their elders, according to researchers from Wake Forest University Baptist Medical Center and colleagues. The new research shows that accumulation of abdominal fat that increases

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-71946492352857500052009-07-19T09:00:00.001-07:002009-07-19T09:00:04.831-07:00Reliv International's GlucAffect(TM) Proven Effective In Clinical Study

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-89082568634337410372009-07-18T21:00:00.001-07:002009-07-18T21:00:12.100-07:00New Role Discovered For Molecule Important In Development Of The Pancreas

New Role Discovered For Molecule Important In Development Of The Pancreas For years researchers have been searching for a way to treat diabetics by reactivating their insulin-producing beta cells, to no avail. Now, they may be one step closer. A protein, whose role in pancreatic development has long been recognized, has been discovered to play an additional and previously unknown regulatory role

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-70255428485633883472009-07-18T09:00:00.001-07:002009-07-18T09:00:06.158-07:00OneTouch(R) Ping™ Glucose Management System Approved By Health Canada

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-78093821707879642412009-07-18T03:00:00.001-07:002009-07-18T03:00:07.637-07:00Medtronic Voluntarily Recalls Specific Lots Of Paradigm(R) Quick-Set(R) Infusion Sets In The United States

Medtronic Voluntarily Recalls Specific Lots Of Paradigm(R) Quick-Set(R) Infusion Sets In The United States Medtronic, Inc. (NYSE:MDT) said that it has initiated a recall of specific lots of Quick-set® infusion sets that are used with MiniMed Paradigm insulin pumps. An infusion set is a thin plastic tube used to deliver insulin from an insulin pump to a diabetes patient, and is typically replaced

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-64791816223389935502009-07-17T21:00:00.001-07:002009-07-17T21:00:06.627-07:00FDA Approves NovoLog(R) Labeling Update - Increasing The Time Patients Can Use And Store NovoLog(R) In Their Pumps From Two Days To Six Days

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-71885270969268954062009-07-17T15:00:00.001-07:002009-07-17T15:00:05.918-07:00Echo Therapeutics To Present At Prestigious 'Innovations In Diabetes' Conference

Echo Therapeutics To Present At Prestigious 'Innovations In Diabetes' Conference Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system, announced that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-31387997410079449732009-07-17T09:00:00.001-07:002009-07-17T09:00:06.558-07:00Grapefruit Ingredient - A Future Treatment For Type 2 Diabetes?

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-1953709761460277652009-07-17T03:00:00.001-07:002009-07-17T03:00:06.248-07:00FDA Approves NovoLog(R) Labeling Update

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-21925805708367216952009-07-16T15:00:00.001-07:002009-07-16T15:00:08.989-07:00Expert Statement Issued About Lantus(R) Following Recent Publications In Diabetologia

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-42345706643017124462009-07-16T03:00:00.001-07:002009-07-16T03:00:10.855-07:00Halozyme Begins Phase 2 Clinical Trial Of Insulin-PH20 In Type 2 Diabetic Patients

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-41633143515653627092009-07-15T21:00:00.001-07:002009-07-15T21:00:08.967-07:00New Blood Glucose Meter Connects To Gaming Systems

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-65050654135911731402009-07-15T15:00:00.001-07:002009-07-15T15:00:06.080-07:00New Blood Glucose Meter Connects To Gaming Systems

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-84659127679599843332009-07-15T03:00:00.001-07:002009-07-15T03:00:06.711-07:00News From The Annals Of Family Medicine: July/August 2009

News From The Annals Of Family Medicine: July/August 2009 The Primary Care Paradox and the Need to Integrate Primary and Specialty Care to Improve the Quality of Healthcare The third in a seven-part series of commentaries to understand health and healthcare With the healthcare reform debate heating up in Washington, D.C., Annals of Family Medicine editor Kurt Stange, M.D., Ph.D.

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-9399908841460192312009-07-14T21:00:00.001-07:002009-07-14T21:00:09.897-07:00Scientists Step Closer To Helping Diabetics Regenerate Insulin Making Cells

Scientists Step Closer To Helping Diabetics Regenerate Insulin Making Cells US scientists have come a step closer to finding a way to help treat people with diabetes by reactivating their own insulin-producing beta cells in the pancreas, although they acknowledge that this goal is still a long way off. They discovered a hitherto unknown role for a well known protein: it helps immature

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.comtag:blogger.com,1999:blog-8104306406266018849.post-14561202675183073132009-07-14T15:00:00.001-07:002009-07-14T15:00:07.193-07:00Scientists Step Closer To Helping Diabetics Regenerate Insulin Making Cells

Mariehttp://www.blogger.com/profile/02012650003662172049noreply@blogger.com